Effect of Hibiscus syriacus Linnaeus extract and its active constituent, saponarin, in animal models of stress-induced sleep disturbances and pentobarbital-induced sleep.
Animals
Apigenin
/ pharmacology
Cerebral Cortex
/ drug effects
Corticosterone
/ blood
Disease Models, Animal
Electroencephalography
Glucosides
/ pharmacology
Hibiscus
Male
Mice, Inbred C57BL
Mice, Inbred ICR
Pentobarbital
Plant Extracts
/ pharmacology
Preoptic Area
/ drug effects
Proto-Oncogene Proteins c-fos
/ genetics
Rats, Sprague-Dawley
Receptors, GABA-A
/ genetics
Sleep
/ drug effects
Sleep Aids, Pharmaceutical
Sleep Wake Disorders
/ blood
Stress, Psychological
/ blood
GABAAR α1
Hibiscus syriacus Linnaeus
Pentobarbital
Sleep
Stress
c-Fos
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
23
07
2021
revised:
05
10
2021
accepted:
05
10
2021
pubmed:
17
12
2021
medline:
26
3
2022
entrez:
16
12
2021
Statut:
ppublish
Résumé
Treatment of sleep disorders promotes the long-term use of commercially available sleep inducers that have several adverse effects, including addiction, systemic fatigue, weakness, loss of concentration, headache, and digestive problems. Therefore, we aimed to limit these adverse effects by investigating a natural product, the extract of the Hibiscus syriacus Linnaeus flower (HSF), as an alternative treatment. In the electric footshock model, we measured anxiety and assessed the degree of sleep improvement after administering HSF extract. In the restraint model, we studied the sleep rate using PiezoSleep, a noninvasive assessment system. In the pentobarbital model, we measured sleep improvement and changes in sleep-related factors. Our first model confirmed the desirable effects of HSF extract and its active constituent, saponarin, on anxiolysis and Wake times. HSF extract also increased REM sleep time. Furthermore, HSF extract and saponarin increased the expression of cortical GABA
Identifiants
pubmed: 34915415
pii: S0753-3322(21)01085-4
doi: 10.1016/j.biopha.2021.112301
pii:
doi:
Substances chimiques
Glucosides
0
Plant Extracts
0
Proto-Oncogene Proteins c-fos
0
Receptors, GABA-A
0
Sleep Aids, Pharmaceutical
0
saponarin
3081Z76OX9
Apigenin
7V515PI7F6
Pentobarbital
I4744080IR
Corticosterone
W980KJ009P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112301Informations de copyright
Copyright © 2021. Published by Elsevier Masson SAS.